Blog

featured image of Accelerating ADC Development and Manufacturing: Streamlining Solutions

Accelerating ADC Development and Manufacturing: Streamlining Solutions

BIOT

📰 ADC Development and Manufacturing: Simplify, Derisk, and Accelerate the Timeline tackles challenges and offers solutions for ADC development and manufacturing. 🧬🔬🎯

featured image of Meet Christopher Riley: The New CEO Revolutionizing Biotechnology

Meet Christopher Riley: The New CEO Revolutionizing Biotechnology

BIOT

🌍 Christopher Riley takes the reins as CEO of Cytiva, a global biotechnology company, driving innovation and growth. 🌟💼🔝

featured image of AstraZeneca's Big Cell Therapy Breakthrough: Gracell Acquisition

AstraZeneca’s Big Cell Therapy Breakthrough: Gracell Acquisition

BIOT

📢 AstraZeneca accelerates cell therapy ambitions through Gracell buy 🌱 Expanding capabilities, boosting oncology portfolio, and driving scientific innovation. 💪🏢🌍

featured image of Novo Nordisk's Bold Move to Boost Diabetes Treatment Production in Ireland!

Novo Nordisk’s Bold Move to Boost Diabetes Treatment Production in Ireland!

BIOT

Novo Nordisk📢 seeks permission in Ireland to expand GLP-1 production🏭, boosting diabetes treatment📈 & job opportunities💼. pharmaceuticals

featured image of Alfasigma SpA's €170m Deal Expands Filgotinib Business

Alfasigma SpA’s €170m Deal Expands Filgotinib Business

BIOT

📅 On January 2nd, 2024, Alfasigma SpA 💪 signed a €170m deal with Galapagos NV to expand their pipeline and market presence 🌍. Additionally, former Galapagos CCO, Michele Manto, joins Alfasigma as CCO Western Europe. 💼

featured image of AstraZeneca's $12bn Chinese Biotech Power Move

AstraZeneca’s $12bn Chinese Biotech Power Move

BIOT

🌍💊 AstraZeneca boosts cell therapy projects by acquiring Gracell Biotechnologies for $1.2bn to fight cancer and autoimmune diseases. 🦠🚀 Expected to close Q1 2024.

featured image of Revolutionary Modeling Boosts Efficiency of rAAV Therapies

Revolutionary Modeling Boosts Efficiency of rAAV Therapies

BIOT

🔬 Scientists from Bristol Myers Squibb and Lund University developed a mechanistic modeling approach for optimizing rAAV therapies. 🧪

featured image of Unlocking Biopharma's Full Potential with IoT

Unlocking Biopharma’s Full Potential with IoT

BIOT

📢 Biopharma industry lags in embracing IoT due to complexity. 🔬 IoT can enhance processes, cut costs. 🏭 Challenges exist. 💡 Sector-wide effort needed. 🌐 Universal solutions, strategies, training can help.

featured image of Revolutionary Algorithms Boost Bioprocess Optimization!

Revolutionary Algorithms Boost Bioprocess Optimization!

BIOT

💡💻🔬Chemical engineering professor Nadav Bar discusses how algorithms optimize bioprocesses, improving productivity and efficiency in biological manufacturing.

featured image of Breaking: Scientists Struggle with Monoclonal Antibody HCPs

Breaking: Scientists Struggle with Monoclonal Antibody HCPs

BIOT

📰 Monoclonal Antibody HCP Challenges: Scientists are still facing the challenge of removing host-cell proteins (HCPs) from bioprocesses. ⚗️🔬🧫